← 返回专利悬崖列表

硫酸阿巴卡韦

Tier C · 观察 / 贸易

Abacavir Sulfate

Viiv Healthcare
原研
1998
首批上市
-
到期年(公开口径)
无销量数据
峰值销售
化学药
类型

靶点:RT

商品名:Ziagenavir、Virol、赛进、Ziagen

适应症(已批准):HIV感染

各地区研发/上市状态

美国
批准上市
1998-12-17
欧盟
批准上市
1999-07-08
中国
批准上市
2002-02-20
日本
批准上市
1999-09-10

合成路线与中间体5 routes

原研路线 × 1优化路线(非专利)× 4工艺路线 × 0

路线按「原研路线 → 优化路线 / 工艺路线(非专利)」排序。每条路线附本站自绘的路线流程图(中间体 → 原料药)与中间体表(编号 / CAS / 英文名),可直接用于供应商开发与询价。流程图由本站依据已授权的结构化数据自行渲染,未使用任何第三方路线图。

原研Route 1步骤 6 · 总收率 260.00 mg
ABAC-009—ABAC-0107226-23-5ABAC-001199395-80-7ABAC-00256-05-3ABAC-0031798043-27-2ABAC-0042028-74-2ABAC-0051798428-85-9ABAC-006—ABAC-007136522-33-3ABAC-00886483-52-5API · 硫酸阿巴卡韦
编号CAS 号中间体名称
ABAC-009-(4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)cyclopent-2-en-1-yl)methanol
ABAC-0107226-23-51,3-dimethyltetrahydropyrimidin-2(1H)-one
ABAC-001199395-80-7N-(4-(hydroxymethyl)cyclopent-2-en-1-yl)acetamide
ABAC-00256-05-34,6-dichloropyrimidin-2-amine
ABAC-0031798043-27-2-
ABAC-0042028-74-24-chlorobenzenediazonium chloride
ABAC-0051798428-85-9-
ABAC-006--
ABAC-007136522-33-3((1S,4R)-4-(2-amino-6-chloro-9H-purin-9-yl)cyclopent-2-en-1-yl)methanol
ABAC-00886483-52-5在售cyclopropanamine
优化Route 2步骤 7 · 总收率 27.00 mg
ABAC-01190719-32-7ABAC-012—ABAC-013—ABAC-014—ABAC-015—ABAC-016—ABAC-017143395-28-2ABAC-018178456-34-3ABAC-019120503-69-7ABAC-020178456-36-5API · 硫酸阿巴卡韦
编号CAS 号中间体名称
ABAC-01190719-32-7(S)-4-benzyloxazolidin-2-one
ABAC-012-pent-4-enoic pivalic anhydride
ABAC-013-(S)-4-benzyl-3-(pent-4-enoyl)oxazolidin-2-one
ABAC-014-(S)-3-((2S,3R)-2-allyl-3-methylpent-4-enoyl)-4-benzyloxazolidin-2-one
ABAC-015--
ABAC-016-(S)-4-benzyl-3-((1R,2R)-2-hydroxycyclopentanecarbonyl)oxazolidin-2-one
ABAC-017143395-28-2(1R,5R)-5-(hydroxymethyl)cyclopent-2-enol
ABAC-018178456-34-3((1R,2R)-2-acetoxycyclopent-3-en-1-yl)methyl acetate
ABAC-019120503-69-7N6-cyclopropyl-9H-purine-2,6-diamine
ABAC-020178456-36-5((1S,4R)-4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)cyclopent-2-en-1-yl)methyl acetate
优化Route 3步骤 3 · 总收率 /
ABAC-007136522-33-3ABAC-017143395-28-2ABAC-021151765-22-9ABAC-022159418-20-9API · 硫酸阿巴卡韦
编号CAS 号中间体名称
ABAC-007136522-33-3((1S,4R)-4-(2-amino-6-chloro-9H-purin-9-yl)cyclopent-2-en-1-yl)methanol
ABAC-017143395-28-2(1R,5R)-5-(hydroxymethyl)cyclopent-2-enol
ABAC-021151765-22-9(3S,3aR,6aR)-3-hydroxy-3,3a,4,6a-tetrahydro-2H-cyclopenta[b]furan-2-one
ABAC-022159418-20-9(4aR,7aR)-4,4a,5,7a-tetrahydrocyclopenta[d][1,3]dioxin-2-one
优化Route 4步骤 4 · 总收率 /
ABAC-02375307-63-0ABAC-024—ABAC-0251309767-90-5ABAC-0261309768-04-4ABAC-0271309768-09-9ABAC-02869971-20-6API · 硫酸阿巴卡韦
编号CAS 号中间体名称
ABAC-02375307-63-02,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl acetate
ABAC-024-di-tert-butyl (1R,3S)-cyclopent-4-ene-1,3-diyl dicarbonate
ABAC-0251309767-90-55-((1R,4R)-4-((tert-butoxycarbonyl)oxy)cyclopent-2-en-1-yl)-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl acetate
ABAC-0261309768-04-45-((1R,4R)-4-azidocyclopent-2-en-1-yl)-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl acetate
ABAC-0271309768-09-9(1S,4R)-methyl 4-azidocyclopent-2-enecarboxylate
ABAC-02869971-20-6((1S,4R)-4-acetamidocyclopent-2-en-1-yl)methyl acetate
优化Route 5步骤 6 · 总收率 0.13 g
ABAC-02963838-48-2ABAC-030146864-12-2ABAC-0311108600-43-6ABAC-0325451-40-1ABAC-0331108600-44-7ABAC-0341108600-45-8ABAC-0351108600-46-9API · 硫酸阿巴卡韦
编号CAS 号中间体名称
ABAC-02963838-48-26-azabicyclo[3.2.0]hept-3-en-7-one
ABAC-030146864-12-2(1S,5R)-6-azabicyclo[3.2.0]hept-3-en-7-one
ABAC-0311108600-43-6(1S,5R)-6-tosyl-6-azabicyclo[3.2.0]hept-3-en-7-one
ABAC-0325451-40-12,6-dichloro-9H-purine
ABAC-0331108600-44-7(1S,4R)-4-(2,6-dichloro-9H-purin-9-yl)-N-tosylcyclopent-2-enecarboxamide
ABAC-0341108600-45-8(1S,4R)-4-(2,6-dichloro-9H-purin-9-yl)-N-methyl-N-tosylcyclopent-2-enecarboxamide
ABAC-0351108600-46-9((1S,4R)-4-(2-chloro-6-(cyclopropylamino)-9H-purin-9-yl)cyclopent-2-en-1-yl)methanol

常见问题(FAQ)

硫酸阿巴卡韦的适应症有哪些?

已批准的适应症包括:HIV感染。

硫酸阿巴卡韦的专利什么时候到期?

硫酸阿巴卡韦的专利到期年暂无公开口径,本页会在数据管道核实后更新。

硫酸阿巴卡韦有几条合成路线?

本站收录 5 条合成路线,最短路线 3 步、总收率 /。每条路线的中间体均带登记编号与 CAS 号。

硫酸阿巴卡韦的关键中间体在哪里可以采购?

硫酸阿巴卡韦的多条路线中间体已挂接 CAS 档案,其中 1 个 CAS 已有优贝德(Unibest)供应网络在售报价,可在本页路线表中直接查看并询价。

如何获取硫酸阿巴卡韦中间体的报价?

在本页选择目标中间体的 CAS 进入档案页,或在询价页直接提交需求;CAS 会自动带入供需撮合流程,由供应网络反馈报价。

数据来源:多源数据交叉核实(仅结构化字段) · 2026-10-22